0
0
6/7/23 at 2:50pm
Organization
Hcplive.com
Author
Connor Iapoce
35 words
0
Comments
Results from the phase 3 CHAMP trial may support low-dose atropine as a pharmacological treatment option for myopia progression in children.
You are the first to view
https://www.hcplive.com/view/low-dose-atropine-eye-drops-reduce-myopia-progression-children
Create an account
or login to join the discussion